ranimustine has been researched along with Brain Ventricular Neoplasms in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hirato, J; Kamiya, M; Kurachi, H; Nakazato, Y; Sasaki, A; Yokoo, H | 1 |
Kurihara, H; Miyazaki, M; Ohye, C; Ono, N; Tamura, M | 1 |
2 other study(ies) available for ranimustine and Brain Ventricular Neoplasms
Article | Year |
---|---|
Neurofibromatosis type 1-associated unusual pleomorphic astrocytoma displaying continual malignant progression.
Topics: Adolescent; Antigens, Nuclear; Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Biomarkers, Tumor; Cerebral Ventricle Neoplasms; DNA Primers; DNA, Neoplasm; Fatal Outcome; Female; Humans; Microfilament Proteins; Muscle Proteins; Neoplasm Recurrence, Local; Neoplasms, Second Primary; Neurofibromatosis 1; Nitrosourea Compounds; Nuclear Proteins; Polymerase Chain Reaction; Polymorphism, Single-Stranded Conformational; Procarbazine; Radiography; Thalamus; Tumor Suppressor Protein p53; Vincristine | 2001 |
Adjunctive treatment for recurrent childhood ependymoma of the IV ventricle: chemotherapy with CDDP and MCNU.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cerebral Ventricle Neoplasms; Child; Child, Preschool; Cisplatin; Drug Administration Schedule; Ependymoma; Female; Follow-Up Studies; Humans; Male; Nitrosourea Compounds; Recurrence; Tomography, X-Ray Computed | 1990 |